Abstract
In this chapter we discuss several of the most relevant subjects related to ethics on Rare Diseases. Some general aspects are discussed such as the socio-psychological problems that confront the patients and their families that finally lead to marginalization and exclusion of patients affected by these diseases from the health programs, even in wealthy countries. Then we address problems related to diagnosis and some ethical aspects of newborn screening, prenatal, pre-implantation diagnosis and reference centers, as well as some conditions that should be met by the persons and institutions performing such tasks. Alternatives of solutions for the most critical situations are proposed. Subsequently the orphan drugs subject is discussed not only from the availability point of view, prizes, industrial practices, and purchasing power in developed and developing societies. The research related to rare disease in children and other especially vulnerable conditions, the need for informed consent, review boards or ethics comities, confidentiality of the information, biobanks and pharmacogenetics are discussed.
References
Abascal-Alonso M, Abajo-Iglesias F, Campos-Castelló J, Feito-Grande L, Herrera-Carranza J, Júdez-Gutiérrez J, MartÃn-Arribas M, MartÃn-Uranga A, Pà mpols-Ros T, Sánchez-MartÃnez M, Terracini B (2007) Recomendaciones sobre los aspectos éticos de las colecciones de muestras y bancos de materiales humanos con fines de investigación biomédica. Rev Esp Salud Pública 81:95–111
Abascal Alonso M, De Abajo Iglesias FJ, Feito Grande L, Herrera Carranza J, Júdez Gutiérrez J, MartÃn Arribas MC, Moya Benavent M, Pà mpols Ros T, Sánchez MartÃnez MJ, Terracini B (2006) Recomendaciones acerca de los aspectos éticos de los programas de cribado de población para enfermedades raras, in Gac Sanit. Comité de Ética del Instituto de Investigación de Enfermedades Raras 27–32
Birbeck D, Drummond M (2007) Research with young children: contemplating methods and ethics. J Educ Enquiry 7(2):21–31
Breckenridge A, Lindpaintner K, Lipton P, Mcleod H, Rothstein M, Wallace H (2004) Pharmacogenetics: ethical problems and solutions. View point. Nature Publishing Group 5:676–680
Canadian Paediatric Society (2008) Ethical issues in health research in children. Paediatr Child Health 13(8):707–712
Council for International Organizations of Medical Sciences (Cioms) (2002) International ethical guidelines for biomedical research involving human subjects. Bull Med Ethics 182:17–23
Christensen P, Prout A (2002) Working with ethical symmetry in social research with children. Childhood 9(4):477–497
De Cenival M (2008) Ethics of research: the freedom to withdraw. Bull Soc Pathol Exot 101(2):98–101
Dimichele D, Miller G, Fins J (2003) Gene therapy ethics and haemophilia: ¿An inevitable therapeutic future? Haemophilia 9:145–152
Dixon-Woods M, Cavers D, Jackson CJ, Young B, Forster J, Heney D, Pritchard-Jones K (2008) Tissue samples as ‘gifts’ for research: A qualitative study of families and professionals. Med Law Int 9:131–150
Elias P (2003) Orphan drugs save lives, but who pays? Associated Press, Newswires
Fernandez CV (2007) Our moral obligations in caring for patients with orphan cancers. CMAJ 176(3):297
Fisher CB, Hoagwood K, Boyce C, Duster T, Frank DA, Grisso T, Robert JL, Macklin R, Beale M, Takanishi R, Trimble JE, Zayas LH (2002) Research ethics for mental health science involving ethnic minority children and youths. Am Psychol 57(12):1024–1040
Foster MW, Royal CDM, Sharp RR (2006) The routinisation of genomics and genetics: implications for ethical practices. J Med Ethics 32:635–638
Goozner M (2004) The $800m pill. The truth behind the cost of new drugs. University of California Press, Berkeley
Greely HT (2001) Informed consent and other ethical Issues in human population genetics. Annu Rev Genet 35:785–800
Grodin MA, Alpert JJ (1988) Children as participants in medical research. Pediatr Clin North Am 35(6):1389–401
Helseth S, Slettebø Å (2004) Research involving children: some ethical issues. Nurs Ethics 11:298–308
Hemphill TA (2010) Extraordinary pricing of orphan drugs: is it a socially responsible strategy for the U.S. Pharmaceutical Industry? J Business Ethics 94(29):225–242
Jefford M, Moore R (2008) Improvement of informed consent and the quality of consent documents. Lancet Oncol 9(5):485–93
Kalfoglou AL, Scott J, Hudson K (2005) PGD patients’ and providers’ attitudes to the use and regulation of preimplantation genetic diagnosis. Reproductive BioMedicine Online. http://www.rhfuonlinc .com/Article/1818 II(4):486–496
Koski G, Aungst J, Kupersmith J, Getz K, Rimon D (2005) Cooperative research ethics review boards: a win-win solution? IRB Ethics Hum Res 27(3):1–7
Lucas GN (2008) Ethics of research in children. Sri Lanka J Child Health 37:69–71
Noah BA (2004) Bioethical malpractive risk and responsibility in human research. J Health Care Law Policy 7(2):175–241
Parker M, Lucassen A (2002) Working towards ethical management of genetic testing. Lancet 360:1685–88
Pelias MK (2004) Research in human genetics: the tension between doing no harm and personal autonomy mini review. Clin Genet 67:1–5
Rantanen E, Hietala M, Kristoffersson U, Nippert I, Schmidtke J, Sequeiros J, Kääriäinen H (2008) ¿What is ideal genetic counselling? A survey of current international guidelines. Euro J Hum Genet 16:445–452
Seyberth HW, Demotes-Mainard J, Wrobel P (2005) Developing a European framework for research on children’s medicines: an examination of the proposed EU regulation on medicinal products for paediatric use. Pediatr Nephrol 20(10.1007/s00467-005-2103-6):1537–1540
Soini S, Ibarreta D, Anastasiadou V, Aymé S, Braga S, Cornel M, Coviello DA, Evers-Kiebooms G, Geraedts J, Gianaroli L, Harper J, Kosztolanyi G, Lundin K, Rodrigues-Cerezow E, Sermon K, Sequeiros J, Tranebjaerg L, Kääriäinen H (2006) The interface between assisted reproductive technologies and genetics: technical, social, ethical and legal issues. Euro J Hum Genet 14(588–645)
Spier R (2004) Human Genetic Testing under Examination by the European Union. Report on a citizens’ and stakeholders’ conference on Human genetic testing, ¿what implications? Sci Eng Ethics 10:579–586
Thomas N, O’kane C (1998) The ethics of participatory research with children. Children Soc 12:336–348
UNESCO (2008) Declaración Universal sobre Bioética y Derechos Humanos. Departamento de Humanidades Biomédicas. Centro de Documentación de Bioética
UNESCO. International Bioethics Committee (IBC) (2007) Report of the International Bioethics Committee of UNESCO (IBC) on Consent. Division of Ethics of Science and Technology: 1–36
http://www.Eurordis.Org. About Rare Diseases. 2009 [cited 2009]
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Netherlands
About this chapter
Cite this chapter
Barrera, L.A., Galindo, G.C. (2010). Ethical Aspects on Rare Diseases. In: Posada de la Paz, M., Groft, S. (eds) Rare Diseases Epidemiology. Advances in Experimental Medicine and Biology, vol 686. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9485-8_27
Download citation
DOI: https://doi.org/10.1007/978-90-481-9485-8_27
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9484-1
Online ISBN: 978-90-481-9485-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)